Abeona Therapeutics Inc. (ABEO)

Trade ABEO now with
5/17/2022 8:27:11 AM Ultragenyx Buys Global Rights To ABO-102 For Sanfilippo Syndrome Type A (MPS IIIA) From Abeona Therapeutics
5/13/2022 8:11:51 AM Abeona Therapeutics Q1 Net Loss $20.8 Mln Or $0.14/Shr Vs Loss Of $16.0 Mln Or $0.17/Shr Last Year
8/10/2021 9:27:51 AM Abeona Therapeutics Appoints Edward Carr As CFO
5/18/2021 7:37:13 AM Abeona Therapeutics Q1 Loss Per Share $0.17 Vs Loss $0.52 Last Year
3/22/2021 7:37:50 AM Abeona Therapeutics Appoints Michael Amoroso As CEO
1/25/2021 7:49:33 AM Abeona Announces Successful Type B Meeting With FDA For Pivotal Phase 3 VIITAL Study Of EB-101
1/23/2018 7:29:01 AM RBC Capital Markets Is Lowering ABEONA THERAPEUTICS INC. (ABEO) FY19 Estimate To -0.61 From -0.44